Inhaled prostacyclin following surgical repair of congenital heart disease - A pilot study

Journal of Cardiac Surgery

Volumn 20, Issue 5, 2005, Pages 436-439

  Carroll, Christopher L ^a   Backer, Carl L ^a,b   Mavroudis, Constantine ^a   Cook, Keith ^a   Goodman, Denise M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DOBUTAMINE; DOPAMINE; MILRINONE; NITRIC OXIDE; PROSTACYCLIN; PROTAMINE; VASODILATOR AGENT;

AEROSOL; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEART INDEX; HEART RATE; HUMAN; INFANT; LUNG ARTERY PRESSURE; MALE; OXYGENATION; PEROPERATIVE CARE; PILOT STUDY; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; VASODILATATION;

ADMINISTRATION, INHALATION; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD, PRESCHOOL; EPOPROSTENOL; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INFANT; PILOT PROJECTS; POSTOPERATIVE CARE; PULMONARY ARTERY; VASODILATOR AGENTS;

EID: 28544447626     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2005.2004135.x     Document Type: Article

References (19)

1. Curran RD, Mavroudis C, Backer CL, et al: Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995;60:1765-1771.
2. Steinhorn RH, Fineman JR: The pathophysiology of pulmonary hypertension in congenital heart disease. Artif Organs 1999;23:970-974.
3. The Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
4. Day RW, Hawkins JA, McGough EC, et al: Randomized controlled study of inhaled nitric oxide after operation for congenital heart disease. Ann Thorac Surg 2000;69:1907-1912.
5. Weinberger B, Laskin DL, Heck DE, et al: The toxicology of inhaled nitric oxide. Toxicol Sci 2001;59:5-16.
6. Zimmerman JL, Hanania NA: Vasodilators in mechanical ventilation. Crit Care Clin 1998;14:611-627.
7. Tsukahara H, Ishida T, Mayumi M: Gas-phase oxidation of nitric oxide: Chemical kinetics and rate constant. Nitric Oxide 1999;3:191-198.
8. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, et al: Comparison of inhaled nitric oxide and inhaled prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 1998;114:780-786.
9. Pappert D, Busch T, Gerlach H, et al: Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 1995;82:1507-1511.
10. Zobel G, Dacar D, Rodl S, et al: Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res 1995;38:198-204.
11. Dahlem P, van Aalderen WM, de Neef M, et al: Randomized controlled trial of aerosolized prostacyclin therapy in children with acute lung injury. Crit Care Med 2004;32:1055-1060.
12. Lowson SM, Doctor A, Walsh BK, et al: Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 2002;30:2762-2764.
13. Soditt V, Aring C, Groneck P: Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn. Intensive Care Med 1997;23:1275-1278.
14. Kelly LK, Porta NF, Goodman DM, et al: Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002;141:830-832.
15. Olschewski H, Walmrath D, Schermuly R, et al: Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996;124:820-824.
16. van Heerden PV, Blythe D, Webb SA: Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS-A pilot study. Anaesth Intensive Care 1996;24:564-568.
17. Walmrath D, Schneider T, Schermuly R, et al: Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;153:991-996.
18. 2) in acute respiratory distress syndrome: Impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response. Crit Care Med 2001;29:57-62.
19. Chen YF, Oparil S: Endothelial dysfunction in the pulmonary vascular bed. Am J Med Sci 2000;320:223-232.